Key result
Genetic testing is recommended for all patients with cardiomyopathy to elucidate underlying genetic variants, enabling accurate diagnosis, risk stratification, and targeted treatment.
Why the study?
Phenotype characterization in cardiomyopathies is challenging due to overlapping features, making genetic testing indispensable for insights into etiology, risks, and guiding treatments.
Genetic testing is a crucial tool for the modern cardiologist in the diagnosis, risk stratification, and management of cardiomyopathies.
Answers are grounded in this paper and cite their sources.
May support genetic testing recommendations in cardiomyopathy; leaves open the need for prospective validation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Scolari et al. (2024) conducted a review in Cardiomyopathies. Genetic testing was evaluated. Genetic testing is recommended for all patients with cardiomyopathy to elucidate underlying genetic variants, enabling accurate diagnosis, risk stratification, and targeted treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: